Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical ...
Anteris Technologies Global Corp. ('Anteris” or the 'Company”) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical ...
Anteris Technologies Global Corp. ('Anteris” or the 'Company”) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical ...
In addition, pursuant to a stock purchase agreement, dated January Anteris has agreed to sell to Medtronic plc (through a wholly owned subsidiary) in a private placement exempt from the registration ...
Aortic stenosis is a narrowing of the aortic valve, which connects the heart to the rest of the body. It affects millions of people and can be fatal if left untreated. At present, there are no ...
COPENHAGEN, Denmark, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that a new pooled analysis showed sustained and clinically meaningful improvements in renal ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
If you were still gaming on Windows 7 or 8 in 2024, almost two years after Microsoft itself abandoned its own children, it's definitely time for an upgrade: Steam's most recent client update is the ...
DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of severe+ tricuspid regurgitation (TR), announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results